Titazepam does not cure SLE, but it helps control disease activity and should be used under medical supervision. Titazepam is an injectable medication that blocks the action between B lymphocyte stimulating factor receptors, proliferation-inducing ligands, and B cell membrane receptors, blocking B lymphocyte proliferation. It is used clinically in combination with conventional therapy to treat patients with SLE who are not responding well to conventional therapy and still have high disease activity. There is currently no cure for SLE, and tetracip is not a cure, but it can help control disease activity. Titazepam should not be used in people who are allergic to the drug’s ingredients and is not recommended for patients with severely active central nervous system lupus, severely active lupus nephritis, AIDS, hepatitis B or C infection, and hypogammaglobulinemia. Adverse reactions such as upper respiratory tract infections, injection site reactions such as itching, swelling, and rash, as well as malaise, fever, nausea, diarrhea, and arthralgia may occur with the use of Titazepam. Titazepam should be used under doctor’s instructions, and if there are any uncomfortable symptoms should be timely feedback to the doctor, timely treatment. It is recommended that SLE patients should consult the rheumatology and immunology department in a timely manner, and standardized treatment should be carried out under the guidance of the doctor.
Support Us
If the above content has been helpful to you, please click the share button to share the article or website. This is the greatest support for us.
Discussion
Share your experience, or seek help from fellow patients.
